Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer.
Pulmatrix develops inhaled therapies for the treatment, prevention, and transmission of infectious and progressive respiratory diseases.
Aldeyra Therapeutics develops drug candidates for capturing and removing free aldehydes to treat and prevent diseases.
Translate Bio develops medicines to treat diseases caused by protein or gene dysfunction.
Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates.
Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.
Fractyl Laboratories is a company developing solutions for the treatment of chronic diseases.
Kaleido Biosciences is a biotechnology company that discovers and develops therapeutic treatments for the patients with diseases.
Taris is building a unique therapeutically-focused urology company developing powerful and targeted new treatments for millions of patients suffering from difficult-to-treat bladder diseases.
Cyteir Therapeutics is engaged in developing medicines for the treatment of cancer and autoimmune diseases.
Kiniksa Pharmaceuticals focuses on the discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.
Keros Therapeutics is a biotechnology company dedicated to the discovery and development of therapeutics for hematological and musculoskeletal disorders.